Former MF Global CEO Jon Corzine is reportedly thinking about launching a hedge fund. The experts disagree on whether he'll succeed.» Read More
CNBC's Bob Pisani discusses the factors behind today's market selloff. Bob says the drop in momentum names and the dip in oil were contributors.
Discussing how turmoil in the Middle East and key housing data impacted today's trading session, with Kenny Polcari, O'Neil Securities director.
CNBC's Scott Cohn runs through the finalists of America's number one state for business.
CNBC's Meg Tirrell speaks to Vertex Pharmaceuticals CEO Dr. Jeffrey Leiden, about its promising two-drug cystic fibrosis treatment, and what it means for sufferers of the disease. Leiden also explains what goes into the pricing of an "orphan drug."
Goldman Sachs chief economist Jan Hatzius, discusses the possibility the Fed will raise rates sooner than expected due to an improving economy. Hatzius says while growth pace is sustainable we are still a long ways before we should tighten monetary policy.
Argentina took its first step in U.S. court toward negotiating with creditors in an effort to end a dispute over unpaid debt and avoid a default. Teresa Barger, Cartica Capital, explains the three big problems facing the republic and why U.S. investors should care.
Discussing the state of the bull market run and the global growth story, with Joe Bell, Schaeffer's Investment Research; Bryan Piskorowski, Wells Fargo Advisors; Sam Stovall, S&P Capital IQ; and Diane Garnick, Clear Alternatives.
Ralph Acampora still thinks the stock market is extended, but he said "everything has changed" since he predicted a correction in May.
TV legend Regis Philbin provides analysis on Micron's quarterly numbers and shares other investment opportunities.
Where is the top state for business in America? CNBC's Scott Cohn explains the process behind the CNBC study and reveals a clue to the winner.
Daniel Curran, University of Dayton president, explains the university's push for the environment and why it divested coal and fossil fuels from its $670 million investment pool.
CNBC.com Managing Editor Allen Wastler reports Buffalo Wild Wings, Google's secretive updates and agricultural tech are the hottest topics on CNBC.com.
Ben Parr, Dominate Fund, weighs in on Google Nest Labs' purchase of Dropcam and whether it is a good move for the company. The "Closing Bell" panel provides perspective.
Lululemon founder Chip Wilson is reportedly working with Goldman Sachs to regain control of the company. Don Peebles, The Peebles Corporation CEO, and Dana Telsey, Telsey Advisory Group CEO, provide perspective.
"Fast Money" trader Steve Grasso provides instant analysis to Micron's quarterly numbers.
Micron is reporting Q3 EPS of $0.79 ex-items on revenue of $3.98 billion, with CNBC's Jon Fortt.
Dissecting current market volatility, with Ralph Acampora, Altaira; Phil Orlando, Federated Investors; Dani Hughes, Divine Capital; and CNBC's Dominic Chu.
Discussing why the Fed is skeptical about the bull rally and what sectors are overvalued, with Jeff Reeves, Investorplace.com editor, and Anthony Chan, Chase chief economist.
The consumer discretionary space has been the worst performing sector this year. CNBC's Seema Mody shows which losing stocks in the index are looking to rebound.
Michael Bonney, Cubist Pharmaceuticals CEO, discusses the FDA's approval of Sivextro, a new antibiotic designed to treat skin infections. Bonney also explains why so many pharma companies have left the antibiotic space.